1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 4: Comparison with other Solitaire patient series
Present Study Machi et al¹¹ Roth et al¹⁰ Castaño et al^9a Stampfl et al¹²
Number of patients 36 56 22 20 18
CS or GA CS GA Both GA GA
Baseline NIHSS score 17.1 15.8 19.4 19 21
ASPECT score 6.6 – – – –
Symptom onset to recanalization (min) 302 353 277 352 289
Successful recanalization 77.8%^{^c} 89%^{^d} 90.9%^{^c} 90%^{^d} 88%^{^c}
NIHSS score at discharge 9 7 – 9.4 –
Symptomatic ICH^{^b} 8.3% 1.7% 13.6% 10%^{^e} 16.6%
mRS ≤2 at 3 months 61.1% 46% 50% 45% 33.30%^{^e}
Mortality at 3 months 22.2% 7.1%^{^e} 18.1% 20% 33%^{^e}
Note:—We show our results with mean in order to favor comparison with other series. Only the Castaño et al⁹ results are presented with median. CS indicates conscious sedation; GA, general anesthesia; ICH, intracranial hemorrhage; min, minutes.
a In this series, the Solitaire device was not always used alone (3 times after the Merci device and twice after intra-arterial tissue plasminogen activator).
↵b Depicted on CT (at 24 hours).
↵c Defined by TICI ≥2a.
↵d Defined by TICI ≥2b.
↵e Evaluation was done at discharge.